DCPH (Deciphera Pharmaceuticals) Backtesting: A Comprehensive Analysis

DCPH (Deciphera Pharmaceuticals) backtesting is a method used to analyze the performance of DCPH stocks. Backtesting DCPH (Deciphera Pharmaceuticals) strategies can help investors make informed decisions. By using backtesting software, investors can test their trading strategies using historical data. This process allows them to evaluate the potential success of their strategies before implementing them in the market. Understanding the results of DCPH (Deciphera Pharmaceuticals) backtesting can provide valuable insights for traders looking to maximize their profits and minimize risks in the stock market. In this article, we will delve into the importance of DCPH (Deciphera Pharmaceuticals) backtesting and how it can benefit investors.

Turn DCPH into profits Start for Free with Vestinda
DCPH
Why Vestinda
  • Track your
    Crypto Portfolio
  • Copy Crypto trading
    strategies
  • Build trading strategies
    with no code
  • Backtest trading strategies
    on Crypto, Forex, Stocks, etc.
  • Demo Trading
    Risk-free Paper Trading
  • Automate trading strategies
    with Live Trading
I want to start earning Start for Free

Quantitative Strategies & Backtesting results for DCPH

Here are some DCPH trading strategies along with their past performance. You can validate these strategies (and many more) for free on Vestinda across thousands of assets and many years of historical data.

Quantitative Trading Strategy: Percentage Price Oscillations with PSAR and Shadows on DCPH

Based on the backtesting results from November 6, 2022, to November 6, 2023, the trading strategy has shown a profit factor of 1.07, with an annualized ROI of 2.89%. The average holding time for trades is 5 days and 16 hours, with an average of 0.28 trades per week. There were a total of 15 closed trades during this period, resulting in a return on investment of 2.89%. The winning trades percentage was 26.67%, and the strategy outperformed buy and hold by generating excess returns of 33.9%. These statistics suggest that the trading strategy has been successful in achieving positive returns and outperforming passive investing strategies.

Backtesting results
Backtesting results
Nov 06, 2022
Nov 06, 2023
DCPHDCPH
ROI
2.89%
End Capital
$
Profitable Trades
26.67%
Profit Factor
1.07
No results icon
No trades were made during this period.

Try adjusting the interval OR Reset to initial period

No results icon
No backtesting results found for selected period.

Choose another period and try again.

Invested amount
Drag handle or
Backtesting period
Reset
Drag handles or pick dates
Backtesting snapshot
The snapshot below does not reflect new Backtesting period results.
DCPH (Deciphera Pharmaceuticals) Backtesting: A Comprehensive Analysis - Backtesting results
Earn from automated trading

Quantitative Trading Strategy: RAVI Reversals with KAMA and Shadows on DCPH

The backtesting results for the trading strategy from November 6, 2022 to November 6, 2023, show a profit factor of 0.82 with an annualized ROI of -5.75%. The average holding time for trades was 5 days 11 hours, with an average of only 0.21 trades per week. There were a total of 11 closed trades during this period, resulting in a return on investment of -5.75% and a winning trades percentage of 9.09%. Despite the negative ROI, the strategy performed better than buy and hold, generating excess returns of 22.66%. Overall, the results suggest that while the strategy may not be profitable in the short term, it has the potential for outperforming the market in the long run.

Backtesting results
Backtesting results
Nov 06, 2022
Nov 06, 2023
DCPHDCPH
ROI
-5.75%
End Capital
$
Profitable Trades
9.09%
Profit Factor
0.82
No results icon
No trades were made during this period.

Try adjusting the interval OR Reset to initial period

No results icon
No backtesting results found for selected period.

Choose another period and try again.

Invested amount
Drag handle or
Backtesting period
Reset
Drag handles or pick dates
Backtesting snapshot
The snapshot below does not reflect new Backtesting period results.
DCPH (Deciphera Pharmaceuticals) Backtesting: A Comprehensive Analysis - Backtesting results
Earn from automated trading

Deciphera Pharmaceuticals Backtesting: A Detailed How-To Guide

  1. Collect historical price data for DCPH.
  2. Choose a backtesting platform or software.
  3. Input the historical data into the platform.
  4. Set up the backtesting parameters and strategy.
  5. Run the backtest and analyze the results.

The Influence of Macro-Economic Trends on DCPH Analysis

The impact of macro-economic events on DCPH backtesting cannot be overlooked. External factors such as interest rate changes, inflation rates, and overall market volatility can significantly affect the results of backtesting.

For example, during times of economic downturn, pharmaceutical companies like Deciphera may experience increased pressure to cut costs or delay research and development projects, which can have a direct impact on performance.

In contrast, during economic booms, DCPH may benefit from increased funding and investor confidence, leading to more positive backtesting results. It is crucial for backtesting models to take into account these macro-economic events to ensure accurate and reliable outcomes.

Analyzing Data Selection for Historical Deciphera Pharmaceuticals Trading.

When selecting historical data for backtesting DCPH, it is crucial to choose a time period that accurately reflects market conditions. Take into account factors such as volatility, economic events, and industry trends. Utilize a diverse range of data sources to ensure the analysis is robust and reliable. Historical data can provide insights into how DCPH may perform in different scenarios and help optimize trading strategies. Keep in mind that past performance is not indicative of future results, but historical data can still be a valuable tool in making informed decisions when backtesting DCPH.

Deciphering DCPH Strategy Amid Market Turbulence

Analyzing DCPH Strategy Performance During Market Crashes

When market crashes occur, it is essential to evaluate how DCPH's strategy performs. An analysis of the impact on their stock price, revenue, and overall performance can provide valuable insights.

During market downturns, DCPH's ability to maintain stable revenue streams and mitigate losses is crucial. Understanding how their strategy adapts to economic turbulence can help investors make informed decisions.

By examining key performance indicators and comparing them to industry benchmarks, investors can gauge the effectiveness of DCPH's strategy during market crashes. Evaluating the company's resilience and ability to weather economic downturns is essential for long-term investment success.

Start earning in 3 easy steps
  1. Create account icon
    Create
    account
  2. Search icon
    Discover profitable
    strategies
  3. Connect exchanges & earn icon
    Connect exchange
    & start earning
I want profitable strategy Open Free Account

Frequently Asked Questions

Is 100 trades enough for backtesting?

While 100 trades can provide some insights into the effectiveness of a trading strategy, it may not be enough to draw definitive conclusions. Ideally, backtesting should include a larger sample size to account for a variety of market conditions and potential anomalies. A larger number of trades can help to better assess the robustness and reliability of a strategy. It is recommended to aim for at least 200-300 trades in backtesting to gain a more comprehensive understanding of its performance.

Is TradingView good for backtesting?

Yes, TradingView is good for backtesting as it offers a user-friendly platform with a wide range of tools and indicators to help you test trading strategies. It allows you to backtest on historical data across different time frames and markets, providing valuable insights into the performance of your strategies. Additionally, TradingView's replay feature allows you to simulate real-time trading scenarios, enhancing the accuracy of your backtesting results. Overall, TradingView is a reliable and efficient tool for backtesting that can help traders make informed decisions based on past performance.

Which trading strategy is most accurate?

There is no one-size-fits-all answer to which trading strategy is the most accurate as it varies depending on market conditions, risk tolerance, and individual trading goals. Some traders may find success with trend-following strategies such as moving averages, while others may prefer counter-trend strategies like mean reversion. Ultimately, the most accurate trading strategy is one that is well-researched, consistently applied, and tailored to the individual trader's unique circumstances. It is important to continually evaluate and adapt your strategy to stay ahead of market movements and maximize profitability.

How to backtest a DCPH strategy with multiple indicators?

To backtest a DCPH (Dual Crossover with Price and Volume) strategy with multiple indicators, you will first need to select the appropriate indicators that complement each other. Next, gather historical price and volume data for the assets you want to analyze. Use a backtesting platform or software to plug in the indicators and test the strategy over a specified time period. Evaluate the performance metrics such as profitability, risk-adjusted returns, and drawdowns. Make any necessary adjustments to optimize the strategy based on the backtest results. Repeat the process on different assets and timeframes to ensure the strategy's effectiveness.

Is there any free backtesting software?

Yes, there are several free backtesting software available for traders and investors to test their trading strategies without risking real money. Some popular free backtesting software options include TradingView, MetaTrader, and Amibroker. These platforms offer a range of tools and features to backtest strategies using historical data, analyze performance metrics, and optimize trading strategies for better results. Traders can use these free backtesting software to identify profitable trading opportunities, refine their strategies, and improve their overall trading performance.

Conclusion

In conclusion, DCPH backtesting is a vital tool for investors to analyze the performance of Deciphera Pharmaceuticals stocks and trading strategies. Understanding the impact of macro-economic events, selecting accurate historical data, and analyzing performance during market crashes are crucial for successful backtesting. By utilizing backtesting platforms and software, investors can optimize their strategies, interpret performance metrics, and make informed decisions to maximize profits and minimize risks in the stock market. Continuous forward testing and strategy optimization are key to staying ahead in the dynamic world of DCPH algorithmic trading.

Turn DCPH into profits Start for Free with Vestinda
Get Your Free DCPH Strategy
Start for Free